New-Onset Severe Anxiety with Episodic Abnormal Movements: Evaluating a Possible Functional Neurological Disorder

Author Name : Hidoc internal team

Psychiatry

Page Navigation

Abstract

New-onset severe anxiety accompanied by episodic abnormal movements presents a complex diagnostic challenge at the intersection of neurology, psychiatry, and emergency medicine. Functional neurological disorder is characterized by genuine, clinically significant neurological symptoms that are incompatible with recognized patterns of neurological disease and are not intentionally produced. Functional movement symptoms may include tremor, dystonia, myoclonus, gait disturbance, and paroxysmal attacks resembling seizures. Anxiety can precede, accompany, or result from these manifestations, but its presence should not be used as a substitute for a positive neurological diagnosis. A careful assessment must exclude urgent structural, toxic-metabolic, epileptic, autoimmune, infectious, and medication-related causes while identifying examination findings that demonstrate internal inconsistency or incongruence. Modern management emphasizes early diagnostic explanation, transparent communication, education, targeted physiotherapy, occupational therapy, psychological interventions, and treatment of comorbid psychiatric or neurological conditions. Emerging research supports mechanism-based rehabilitation, multidisciplinary care, digital monitoring, and individualized approaches that address abnormal attention, threat processing, predictive motor control, and maladaptive illness beliefs. This review summarizes the disease burden, mechanisms, risk factors, clinical presentation, diagnostic strategy, treatment principles, recent advances, and guideline-informed recommendations for clinicians evaluating this presentation.

Introduction

Severe anxiety with intermittent abnormal movements may be encountered in emergency departments, primary care, neurology clinics, and psychiatric services. The symptoms can be dramatic and disabling, including shaking, jerking, sustained postures, collapsing, impaired walking, or attacks associated with breathlessness and intense fear. Clinicians must avoid two opposing errors: attributing all symptoms to anxiety without adequate neurological assessment, or pursuing repeated investigations after a positive diagnosis of functional neurological disorder has been established. Functional symptoms are involuntary and real to the patient, even when conventional structural investigations are normal.

A diagnosis of functional neurological disorder should be made positively, using characteristic clinical signs rather than solely by exclusion. The evaluation should also recognize that functional neurological disorder and organic neurological disease can coexist. New-onset severe symptoms require assessment of time course, medication exposure, substance use, sleep, trauma, infection, metabolic disturbance, seizure risk, and personal or family history of movement disorders. The clinical objective is not merely to label symptoms, but to identify the most plausible mechanisms, communicate the diagnosis effectively, and establish a safe plan for recovery.

Epidemiology / Disease Burden

Functional neurological disorder is among the more common reasons for referral to general neurology, and functional movement symptoms constitute an important subgroup. Estimates vary according to setting and diagnostic criteria, but functional symptoms may account for a substantial proportion of outpatient neurological presentations. Functional seizures and functional movement disorders frequently affect working-age adults, although children, adolescents, and older adults may also be affected. Women are represented disproportionately in many clinical cohorts, but this pattern should not lead to diagnostic stereotyping.

The disease burden is driven by disability, social restriction, loss of employment, emergency presentations, diagnostic uncertainty, and repeated testing. Severe anxiety may amplify symptom vigilance, autonomic arousal, avoidance, and fear of movement. Delayed diagnosis is associated with poorer functional outcomes, whereas an early, confident, and respectful explanation may reduce unnecessary investigations and improve engagement with rehabilitation. The economic burden includes direct healthcare costs and indirect effects related to reduced productivity and caregiver dependence.

Pathophysiology

Current models describe functional neurological disorder as a disorder of nervous system functioning involving altered predictive processing, attention, agency, salience attribution, and motor control. The brain continuously generates predictions about bodily states and movement, while sensory feedback updates those predictions. In functional symptoms, abnormal prior expectations or threat-related predictions may dominate incoming sensory information, producing involuntary movements or altered motor output without a structural lesion.

Neuroimaging and neurophysiological studies have identified differences in networks involved in emotion, self-monitoring, motor planning, and attention, although no single biomarker is currently diagnostic. Anxiety may increase autonomic activation and attentional capture by bodily sensations, reinforcing a cycle of threat appraisal, muscle tension, abnormal movement, and further fear. Precipitating events can include injury, illness, pain, panic, sleep deprivation, or psychological stress, but an identifiable stressor is not required. The absence of trauma or psychiatric illness does not exclude the diagnosis.

Risk Factors

Risk factors are heterogeneous and should be interpreted as contributors rather than proof of causation. They may include a history of anxiety, depression, panic symptoms, trauma-related disorders, chronic pain, migraine, fatigue, dissociation, previous functional symptoms, or adverse healthcare experiences. Physical injury, infection, surgery, medication changes, sleep disruption, and prolonged stress may act as precipitating factors. Personality traits, health anxiety, and heightened interoceptive awareness can influence symptom persistence, but clinicians should avoid language implying that symptoms are fabricated or voluntary.

Medication and substance exposure require particular attention. Stimulants, antidepressant changes, dopamine-blocking drugs, withdrawal from sedatives or alcohol, recreational substances, and excessive caffeine may contribute to tremor, akathisia, dystonia, seizures, or severe anxiety. A complete risk assessment should also consider suicidality, self-neglect, domestic violence, safeguarding concerns, and functional decline.

Clinical Features

Functional movement symptoms are often variable, distractible, entrainable, and inconsistent with recognized neurological syndromes. Tremor may change frequency or distribution with distraction, or adopt the rhythm of voluntary movement in another limb. Jerks may occur with variable latency and improve with alternative tasks. Functional dystonia can present with fixed or painful postures, often with an abrupt onset and unusual distribution. Gait may show knee buckling, excessive sway without falls, dragging, or dramatic pauses that improve when attention is diverted.

Episodes may occur alongside palpitations, hyperventilation, chest discomfort, derealization, trembling, and fear of dying. These features can resemble panic attacks, epileptic seizures, syncope, or paroxysmal dyskinesia. Red flags requiring urgent investigation include persistent altered consciousness, progressive focal deficits, fever, meningism, severe headache, new cognitive impairment, tongue injury with a compatible event history, prolonged postictal confusion, unexplained falls, or signs of toxic-metabolic illness. The phenomenology, triggers, duration, recovery, witness description, and video documentation are often diagnostically valuable.

Diagnosis

Diagnosis begins with a detailed history and neurological examination. Clinicians should characterize the movements rather than relying on the patient’s diagnostic terminology. Examination maneuvers may assess distractibility, entrainment, variability, coherence with voluntary movement, and the relationship between observed deficits and functional anatomy. For functional seizures, capture of a typical event on video-electroencephalography may be useful, although a normal electroencephalogram between episodes does not independently establish the diagnosis.

Investigations should be guided by clinical probability. Depending on presentation, testing may include metabolic studies, toxicology, medication review, neuroimaging, electroencephalography, autoimmune evaluation, or assessment for endocrine and infectious disease. Excessive testing can reinforce fear and increase healthcare dependence, but premature closure is unsafe. Diagnostic communication should explain the positive findings, affirm that symptoms are real and involuntary, describe the expected mechanism, and state what conditions have been reasonably excluded. Shared review of examination findings can be more effective than reassurance alone.

Treatment & Management

Management is most effective when individualized and multidisciplinary. The initial consultation should establish a coherent formulation linking symptoms, examination findings, anxiety, and maintaining factors without implying intentional production. Written information and a clear follow-up plan are important. Physiotherapy for functional motor symptoms focuses on retraining automatic movement, redirecting attention, normalizing gait, reducing excessive co-contraction, and progressively restoring activity. Occupational therapy can address daily function, pacing, workplace adaptation, and avoidance behaviors.

Psychological treatment may include cognitive behavioral therapy, acceptance-based approaches, trauma-focused treatment when indicated, or other structured interventions targeting catastrophic interpretations, hypervigilance, avoidance, and autonomic arousal. Anxiety, depression, insomnia, pain, migraine, and substance use should be treated according to established standards. Pharmacological therapy does not directly cure functional movements, and sedative prescribing should be cautious because dependence, cognitive impairment, and reinforcement of illness behavior may result. Antidepressant treatment may be appropriate for a clearly diagnosed comorbid anxiety or depressive disorder.

Clinicians should develop a relapse plan identifying early warning signs, sleep and activity strategies, medication changes, and appropriate points of contact. Emergency services remain appropriate when new red flags appear, but repeated urgent assessments for unchanged, previously characterized episodes should be minimized through coordinated care.

Recent Advances / Emerging Therapies

Recent advances emphasize mechanism-based treatment rather than a single universal protocol. Specialized rehabilitation programs combine neurological education, motor retraining, psychological therapy, and management of fatigue and pain. Studies are examining whether interventions tailored to predominant mechanisms, such as abnormal attention, threat prediction, dissociation, or impaired sense of agency, improve outcomes compared with nonspecific care.

Digital symptom diaries, wearable motion sensors, tele-rehabilitation, and remote psychological interventions may support longitudinal assessment and access to specialist services. Research is also exploring neurophysiological markers, computational models of predictive processing, and noninvasive neuromodulation. These approaches remain investigational and should not replace a careful clinical diagnosis. Future trials require standardized outcome measures, longer follow-up, representative patient populations, and transparent reporting of comorbid neurological and psychiatric disease.

Guideline Recommendations

Guideline-consistent care supports a positive diagnosis based on clinical evidence, prompt communication, avoidance of stigmatizing terminology, and early referral to clinicians experienced in functional neurological disorder. Neurological emergencies and important mimics must be assessed according to the presenting syndrome. Investigations should be proportionate, clinically justified, and reviewed with the patient. A multidisciplinary plan should address movement symptoms, anxiety, physical conditioning, sleep, pain, psychosocial stressors, and occupational goals.

Patients should be informed that functional does not mean imagined, voluntary, or untreatable. Clinicians should avoid presenting normal scans as evidence that nothing is wrong. Treatment decisions should be shared, progress should be measured using function as well as symptom frequency, and follow-up should be sufficiently sustained to support behavioral change. When diagnostic uncertainty persists, reassessment is appropriate rather than either dismissing symptoms or ordering indiscriminate tests.

Conclusion

New-onset severe anxiety with episodic abnormal movements demands a structured, compassionate, and neurologically informed assessment. Functional neurological disorder is diagnosed through positive clinical features of inconsistency and incongruence, while maintaining vigilance for epilepsy, structural disease, toxic-metabolic disorders, autoimmune illness, medication effects, and other mimics. Anxiety frequently interacts with altered attention, threat processing, autonomic arousal, and motor prediction, but it does not invalidate the physical reality of the symptoms. Early explanation, targeted rehabilitation, psychological treatment, management of comorbidities, and coordinated follow-up offer the strongest current framework for improving function and reducing unnecessary healthcare use. Continued research into biomarkers, mechanism-based interventions, digital monitoring, and multidisciplinary models may further strengthen diagnostic precision and therapeutic outcomes.

Featured News
Featured Articles
Featured Events
Featured KOL Videos

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot